GLOBAL HOLISTIC HEALTH SUMMIT HOLISTIC AND INTEGRATED MEDICINE FOR THE 21ST CENTURY

BANGALORE, INDIA 12TH-17TH January, 2003 2003年1月、インドのバンガロールにおいて、池川哲郎博士（JAIM常任理事）は以下の内容で学会発表。 "ISHOKU-DOUGEN" DRUG AND FOOD ARE FROM THE SAME ORIGIN, EFFECTIVENESS OF EDIBLE MUSHROOMS FOR HEALTH CARE Tetsuro Ikekawa Japanese Association for Integrative Medicine (JAIM): 12-15-14,Sanshin Bldg. Uchikanda, Chiyoda-ku, Tokyo, Japan Beneficial effects of mushrooms have been world-widely developed. The beginning was in our studies at National Cancer Center of Japan, that Japanese edible mushrooms have been proved to have ﾒHost-mediatedﾓ antitumor activities. The aqueous extracts of edible mushrooms showed so high growth-inhibitory activity against solid sarcoma 180. Many antitumor polysaccharides were isolated from the mushrooms, and among them, a β-(1-3)-glucan isolated from Lentinus edodes (Shiitake in Japanese) was named Lentinan and used clinically as an injection by a narrow adaptation in Japan. However, substances having the antitumor activity by per oral were a low molecular weight protein bound polysaccharide. It was first isolated from another popular edible mushrooms, Flammulina velutipes (Enokitake), and especially useful by p.o. in combination with surgery and other antitumor agents. On the other hand, an epidemio-logical study in Nagano Prefecture, Japan indicated that the cancer death-rate of farmers producing F. velutipes as a main occupation was remarkably lower than that of common people in the Prefecture. Detailed epidemiological study is now in progress by a leadership of the National Cancer Center. Cancer prevention effect of Hypsizigus marmoreus (Bunashimeji), one of the most popular edible mushrooms had also high antitumor activity and preventive effect for tumor metastasis. Cancer preventive study is as follows; the control mice were bred with an ordinary feed and the treated mice with a feed containing 5% of dried fruit-body of H. marmoreus. All mice were i.d injected with a strong carcinoma, methyl cholanthrene, and carcinogenesis of the mice was investigated. As a result of the 76-week observation, 21of 36 mice developed tumors in the control, but only 3 of 36 mice in the treated group had tumors. The mechanism of cancer inhibitory and preventive activities of edible mushrooms was due to immunopotentiation and antioxidant activity. Thus, the intake of mushrooms proved to be effective in cancer prevention and growth-inhibition. Based on the result described above, EEM (Extracts of Edible Mushrooms) is supplied as a supplement and given a clinical effectiveness by a case-control study. So it was to be effective for treatment of ﾒMibyouﾓ (pre-symptomatic medicine or clinical stages) or for prevention from Mibyou to diseases. It is said in Oriental traditional medicine from the ancient times that Medicine and Food have the same origin (Ishoku Dougen or Yakushoku Dougen in Japanese). This is identical with our conclusion from mushroom-studies.